BackHemagen Diagnostics Overview

Hemagen Diagnostics Other Liabilities

Latest other liabilities for HMGN: $0.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

Hemagen Diagnostics Other Liabilities History

Loading

Hemagen Diagnostics vs. peers: Other Liabilities Comparison

Loading

Hemagen Diagnostics Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Hemagen Diagnostics (HMGN) FAQ

Hemagen Diagnostics (HMGN) currently reports a other liabilities of $0 as of September 2012. In the prior-year period, the figure was $0. Use the charts on this page to explore Hemagen Diagnostics's other liabilities history and peer comparisons.

Hemagen Diagnostics's other liabilities changed from $0 to $0 (period ending September 2012). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Hemagen Diagnostics reported $0 in other liabilities as of September 2012. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other liabilities of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Hemagen Diagnostics, and consider following HMGN for alerts when major investors trade the stock.

Hemagen Diagnostics is classified in the Healthcare sector. On other liabilities, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HMGN with unrelated industries.